There were no significant differences in baseline characteristics between patients with and without OCT for the culprit lesion at 1 year follow-up, except for the frequency of dyslipidemia and P2Y12 inhibitor at baseline (Supplementary Table 2). The gene discussed is P2RY12; the disease is metabolic syndrome.